The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anti-PD1 antibody pucotenlimab in combination with bevacizumab or lenvatinib in a phase II study for the treatment of advanced hepatocellular carcinoma (aHCC).
 
Hong Zhao
No Relationships to Disclose
 
Aiping Zhou
No Relationships to Disclose
 
Jianfei Tu
No Relationships to Disclose
 
Yuxian Bai
No Relationships to Disclose
 
Xianhai Mao
No Relationships to Disclose
 
Tianqiang Song
No Relationships to Disclose
 
Bo Li
No Relationships to Disclose
 
Wenxiang Dai
No Relationships to Disclose
 
Jing Lv
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Xu Che
No Relationships to Disclose
 
Lianxin Liu
No Relationships to Disclose
 
Lianhai Zhang
No Relationships to Disclose
 
Wei Wu
No Relationships to Disclose
 
Jianqiang Cai
No Relationships to Disclose